Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29087457 | 0.94 | CYP3A4 (0.59) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| SCHEMBL27899734 | 0.94 | CYP3A4 (0.59) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| SCHEMBL9716383 | 0.94 | CYP3A4 (0.59) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| SCHEMBL6895340 | 0.86 | MIF (0.56) | CYP3A4TSHRCYP1A2TRPA1MIF | |
| SCHEMBL21089 | 0.86 | MIF (0.44) | CYP3A4TSHRCYP1A2TRPA1MIF | |
| SCHEMBL22588334 | 0.86 | CYP3A4 (0.48) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| SCHEMBL452752 | 0.86 | P2RY6 (0.59) | CYP3A4TSHRCYP1A2TRPA1TDP1 | |
| SCHEMBL10784417 | 0.85 | CYP3A4 (0.49) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| SCHEMBL28279913 | 0.84 | CYP3A4 (0.47) | CYP3A4TSHRCYP1A2TRPA1MAPK1 | |
| Water SCHEMBL14972874 | 0.84 | MIF (0.43) | CYP3A4TSHRTRPA1MIFALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 479 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| EP-4021629-B1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-04 | — | — | EP | claimed |
| US-20230340374-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| CN-116544501-A | Electrolyte and application thereof | 广州天赐高新材料股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| US-20230166230-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | GIVAUDAN SA (CH) | 2023-06-01 | — | — | US | claimed |
| EP-4157203-A1 | ENCAPSULATED COMPOSITION COMPRISING CORE-SHELL MICROCAPSULES AND PROCESS FOR ITS PREPARATION | Givaudan SA (CH) | 2023-04-05 | — | — | EP | claimed |
| CN-115666494-A | Encapsulated compositions comprising core-shell microcapsules and methods of making the same | 奇华顿股份有限公司 | 2023-01-31 | — | — | CN | claimed |
| US-20220306970-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2022-09-29 | — | — | US | claimed |
| EP-4021629-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2022-07-06 | — | — | EP | claimed |
| CN-114340775-A | Improvements in or relating to organic compounds | 奇华顿股份有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20050287560-A1 | Method for preparing substrates having immobilized molecules and substrates | NANOSPHERE, INC. | 2005-12-29 | — | — | US | claimed |
| WO-2005108625-A2 | METHOD FOR PREPARING SUBSTRATES HAVING IMMOBILIZED MOLECULES AND SUBSTRATES | NANOSPHERE, INC. (US) | 2005-11-17 | — | — | WO | claimed |
| EP-1569512-A2 | PARTICULATE SUSPENSIONS | Syngenta Limited (GB) | 2005-09-07 | — | — | EP | claimed |
| WO-2004052099-A2 | PARTICULATE SUSPENSIONS | SYNGENTA LIMITED (GB) | 2004-06-24 | — | — | WO | claimed |
| US-5402839-A | Hardness of flat-free and void free tires is formed by reacting polyol, polyisocyanate and aromatic polyamine in presence of extender oil | GUPTA LAXMI C (US) | 1995-04-04 | — | — | US | claimed |
| EP-0387894-B1 | Chain-extending agent for 4,4'-diphenyl methane diisocyanate prepolymers for casted polyurethane elastomers | LONZA AG (CH) | 1994-06-08 | — | — | EP | claimed |
| US-5026815-A | Chlorinated 4,4**1-methylenebisanilines | LONZA LTD. (CH) | 1991-06-25 | — | — | US | claimed |
| US-4888442-A | ADDING ORGANIC SOLVENT, THEN AGITATION, EVAPORATION | MOBAY CORPORATION (US) | 1989-12-19 | — | — | US | claimed |
| US-4619970-A | CHROMATOGRAPHIC RESOLUING AGENT OF SILION GEL BONDED TO OPTICALLY ACTIVE POLYMER | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1986-10-28 | — | — | US | claimed |
| EP-0083232-A1 | Aqueous compositions comprising blocked isocyanate crosslinking agent | FORD MOTOR COMPANY LIMITED (GB) | 1983-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | CYP3A4 4123/4885TSHR 2858/4885CYP1A2 3106/4885 |
| US-20220306970-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | PHOSPHO1, LIPA, LIPC | CYP3A4 3635/4885TSHR 3566/4885CYP1A2 3725/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.